Johnson and Johnson India Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst monitors and assesses the safety of medicines after they are marketed, collecting and evaluating adverse event reports from healthcare professionals and patients. Day to day, they triage cases, code medical terms, assess causality and seriousness, and prepare reports for regulatory authorities. In a company like Johnson and Johnson India, the role supports global safety databases and ensures compliance with Indian and international pharmacovigilance regulations.

Role and Technical Knowledge

1. 1

   What is the difference between an adverse event and an adverse drug reaction?

   An adverse event is any untoward medical occurrence after drug use, which may not be causally related. An adverse drug reaction is a response to a drug that is noxious and unintended, with a reasonable causal relationship.

2. 2

   What are the four minimum criteria for a valid ICSR?

   An identifiable patient, an identifiable reporter, a suspect product, and an adverse event. Missing any makes the case invalid for reporting.

3. 3

   Explain the WHO-UMC causality assessment categories.

   Certain, probable, possible, unlikely, conditional, and unassessable. Be ready to give a brief example for one category.

4. 4

   What is the difference between serious and severe in pharmacovigilance?

   Serious refers to patient outcome (death, hospitalisation, disability, etc.) and is a regulatory term. Severe describes the intensity of the event, which may not be serious.

Practical Scenarios

1. 5

   You receive a call from a patient reporting a rash after taking a new medicine. Walk me through how you would handle this.

   Collect all four minimum criteria, ask about timing, dose, concomitant meds, and medical history. Document verbatim, assess seriousness, and enter into the safety database within timelines.

2. 6

   How would you handle a case where the reporter is anonymous but provides detailed clinical information?

   An anonymous reporter makes the case invalid because the reporter is not identifiable. You should still document the information and follow up if possible, but it cannot be reported as a valid ICSR.

3. 7

   You notice a cluster of similar adverse events from one batch of a product. What do you do?

   Recognise this as a potential signal. Escalate to the signal detection team, check if it meets criteria for a batch recall or regulatory notification, and document your actions.

4. 8

   A healthcare professional reports an event that is already listed in the product label. How do you process it?

   It is still a valid adverse event and must be processed. Expectedness affects reporting requirements but does not make the case invalid. Follow standard case processing and reporting timelines.

Behavioural and Situational

1. 9

   Tell me about a time you had to follow a strict process even when you were in a hurry.

   Use the STAR method. Show that you understand the importance of compliance and accuracy over speed in pharmacovigilance.

2. 10

   How do you handle a situation where a colleague makes a data entry error that could affect a safety report?

   Focus on patient safety and data integrity. Describe how you would politely point out the error, correct it through proper channels, and suggest preventive measures.

3. 11

   Why do you want to work in pharmacovigilance, and why this company?

   Show genuine interest in patient safety and drug safety monitoring. Mention the company's reputation in healthcare and your desire to learn from its global pharmacovigilance systems.

4. 12

   Describe a time you had to explain a complex medical concept to someone without a science background.

   Highlight your communication skills and ability to simplify without losing accuracy. This is key when interacting with reporters or cross-functional teams.

HR and Career Fit

1. 13

   What do you know about the drug regulatory environment in India for pharmacovigilance?

   Mention CDSCO, the Pharmacovigilance Programme of India (PvPI), and Schedule Y requirements. Show awareness of reporting timelines and the role of the National Coordination Centre.

2. 14

   How do you prioritise your work when you have multiple cases with different deadlines?

   Explain that serious and expedited cases take priority, followed by non-serious cases. Mention using checklists, time management tools, and communicating with your manager if needed.

3. 15

   Where do you see yourself in three years in this role?

   Show commitment to growing within pharmacovigilance, such as moving from case processing to signal detection or becoming a subject matter expert. Avoid saying you want to leave the field.